Here are some important highlights from the meeting.
Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
 

 

New Research on Mechanisms in the Development of PF
— Dr. Sonye K. Danoff

Exploring New Therapeutic Avenues for Managing PF
— Dr. Sonye K. Danoff

 


New Approaches to the Diagnosis of IPF
— Dr. Timothy P. Whelan

Updates on Registry Enrollment and Growth of the Care Center Network
— Dr. Timothy P. Whelan

 


Exploring the Basic Mechanisms that Contribute to Development of Lung Fibrosis
— Drs. Danoff and Whelan

Transcript

Gene Abnormalities and ILD
— Drs. Danoff and Whelan
 

Transcript

 


Environmental Influences on the Development of Pulmonary Fibrosis
— Drs. Danoff and Whelan

Genetics and Personalized Medicine for Patients with Pulmonary Fibrosis
— Drs. Danoff and Whelan

 

 

Access other Therapeutic Areas: